SemaglutideRx
GLP-1 Receptor Agonist

SemaglutideRx
GLP-1 Receptor Agonist
TirzepatideRx
Dual GLP-1 + GIP Receptor Agonist
Semaglutide ODT PillsRx
GLP-1 Receptor Agonist - Oral Dissolving Tablet
Tirzepatide ODT PillsRx
Dual GLP-1 + GIP Receptor Agonist - Oral Dissolving Tablet
Men's Complete Hair Growth PillRx
Minoxidil, Finasteride, Biotin
Men's Advanced Hair SprayRx
Minoxidil, Finasteride, Fluocinolone, Tretinoin
Women's Premium Hair SprayRx
Minoxidil, Tretinoin, Fluocinolone, Biotin, Melatonin
Women's Complete Hair Growth PillRx
Minoxidil, Vitamin E, Biotin
Written by Join Luma Team
November 8, 2026 · 7 min read

Tirzepatide can cause diarrhea, particularly during dose escalation; small meals, fluid replacement, and clinician-guided care can help.
In Zepbound weight-management trials, diarrhea occurred in 19%–23% of treated adults, depending on dose, versus 8% on placebo.
Diarrhea was reported by 19%, 21%, and 23% of adults assigned to Zepbound 5 mg, 10 mg, and 15 mg in pooled weight-management trials, compared with 8% receiving placebo. The Zepbound prescribing information counts reports across the trials, not the chance of a loose stool on a particular injection day.
| Treatment group | Reported diarrhea |
|---|---|
| Placebo | 8% |
| Zepbound 5 mg | 19% |
| Zepbound 10 mg | 21% |
| Zepbound 15 mg | 23% |
These figures belong to the FDA-approved injection studied. Join Luma compounded tirzepatide injections and once-daily oral ODT tablets were not those products, and they do not have these established trial frequencies. The table helps frame the symptom as recognized, not as something you should ignore when it becomes disruptive.
Tirzepatide acts on GIP and GLP-1 receptors and changes appetite and digestive function. Although it delays stomach emptying, its digestive effects are not limited to constipation: diarrhea is also a common reported adverse reaction. Meal composition, other medicines, and infection may contribute, so timing alone does not prove a medication is the only cause.
“The majority of nausea, vomiting, and/or diarrhea events occurred during dose escalation and decreased over time.”
The escalation pattern means new loose stools may appear after a prescribed increase and later become less frequent. It does not establish a fixed adjustment period or mean every case will resolve without help. Repeated watery stools or difficulty maintaining fluids warrants contact with your clinician.
Record the last dose date, any recent prescribed increase, approximate stool frequency, and other symptoms such as fever, pain, or vomiting. Our tirzepatide side-effects guide puts diarrhea in context with other digestive effects. Do not accelerate, repeat, or change doses to test whether the symptom improves.
Replacing fluid and electrolytes is the first priority. Take frequent small sips rather than forcing a large drink if you are nauseated. Water can help with mild fluid loss; with repeated watery stools, an oral rehydration solution can replace both water and salts.
NIDDK’s diarrhea treatment guidance describes oral rehydration solutions and other electrolyte-containing liquids. People with diabetes, kidney disease, immune problems, or other important medical conditions should ask their clinician about the best solution and amount. Fluid and sodium needs are not identical for every patient.
A sports drink is not automatically the best replacement for significant losses, and very sweet beverages may be poorly tolerated. If drinking does not keep up with losses, home hydration is no longer enough; get assessed promptly.
You usually do not need to stop eating entirely. Small portions of foods you tolerate can maintain energy while your gut settles: examples include rice, oatmeal, potatoes, toast, broth-based soup, or a modest serving of lean protein. These are starting ideas, not a required restrictive diet.
Temporarily limit foods that clearly worsen symptoms, especially very fatty meals, large portions, or sugar alcohols in some sugar-free sweets and protein products. Some people notice that dairy or caffeine aggravates diarrhea. Review recent changes before eliminating entire food groups long term.
As appetite returns, NIDDK advises that many people can return to their normal diet even if diarrhea has not fully stopped. Build back variety rather than staying on toast alone for days. If eating triggers significant pain or vomiting, seek medical advice instead of repeatedly testing foods.
Read tirzepatide and alcohol before returning to drinking. During an active episode, a nonalcoholic option is the simpler choice; a beverage that was previously comfortable may now worsen your digestive symptoms.
Ask your clinician or pharmacist before adding loperamide or bismuth subsalicylate, especially if symptoms recur after each dose or you take other medicines. NIDDK notes that OTC products can be useful for some acute diarrhea, but they are not appropriate in every situation and do not correct dehydration.
Do not self-treat bloody diarrhea or diarrhea with fever using an antidiarrheal without medical guidance. Severe abdominal pain, marked swelling, or black tarry stool also needs assessment rather than a medication to hide the symptom. Tell the clinician about recent antibiotics, travel, sick contacts, and supplements.
Check whether a laxative, magnesium supplement, metformin, or a new food product could be contributing. Do not stop prescribed medicines independently, but bring the full list to your clinician. A clear review may be more useful than repeatedly adding a second medication to counteract the first.
Zepbound’s label warns about acute kidney injury due to volume depletion. Diarrhea, particularly with vomiting or poor intake, can cause enough fluid loss to affect the kidneys. The risk deserves extra attention during initiation and escalation, and if you already have kidney disease or take medicines that affect fluid balance.
Seek urgent care for inability to keep liquids down, very little urine, fainting, confusion, severe persistent abdominal pain, or significant blood in stool. Severe pain that radiates toward the back can signal pancreatitis; do not assume it is routine diarrhea. Call 911 for collapse or life-threatening illness.
Contact your clinician if diarrhea lasts more than two days, returns repeatedly, or prevents normal eating, drinking, or work; call sooner if symptoms are worsening or you have important medical conditions. Before a planned increase, discuss ongoing symptoms with the prescriber. Follow the prescription label and individualized advice, not a schedule borrowed from another patient.
Join Luma offers clinician-reviewed care, and your own prescription label is the starting point for medication instructions. Send the clinician a short record of your diarrhea and hydration changes: when they began, your current prescribed dose, the last dose date, food and fluid intake, and other medicines or supplements. Include whether you can keep liquids down and whether symptoms interfere with daily activities.
Join Luma support is available 24/7 through the patient portal or at support@joinluma.com. Support can help you reach the appropriate care team, but it is not an emergency service. Do not wait for a portal reply when severe symptoms need urgent assessment. Ask your clinician before changing a dose, delaying an increase, or adding an over-the-counter remedy.
Join Luma’s once-daily oral ODT options include ondansetron for anti-nausea support; weekly injections are a different formulation. Ondansetron does not prevent every gastrointestinal problem and can itself contribute to constipation. Tell the clinician about existing bowel difficulties and all medicines you take.
The percentages discussed here come from FDA-approved brand-product studies, not Join Luma patient outcomes. Compounded tirzepatide is not FDA-approved, and compounded injections and ODT tablets were not the products studied in those trials. Your clinician can explain how this distinction applies to your prescription and your personal treatment plan.
Same price every dose
A licensed provider reviews your intake. If treatment is appropriate, your medication ships free with expedited two-day delivery.
Get startedCompounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality before marketing. Brand-product study results describe the FDA-approved products studied. A licensed clinician decides whether treatment is appropriate; follow your prescription label and your clinician's directions.
This article is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Individual treatment decisions should be made with a licensed healthcare provider.
Diarrhea was reported by 19%–23% of adults taking Zepbound in pooled weight-management trials, depending on dose, versus 8% on placebo. These are approved-injection data, not compounded-product rates.
Zepbound labeling says most nausea, vomiting, or diarrhea events occurred during escalation and decreased over time. Other causes are possible, so report persistent or severe symptoms.
Water helps, but repeated diarrhea may also require electrolyte replacement. Ask your clinician about oral rehydration solution, especially with kidney disease or diabetes.
Ask your clinician or pharmacist whether it fits your symptoms and medication list. Do not use an antidiarrheal to self-treat bloody diarrhea or fever without medical advice.
Seek urgent care for very little urine, fainting, confusion, inability to retain liquids, or severe persistent abdominal pain. Call 911 for collapse or life-threatening symptoms.
Do not change the dose on your own. Send your Join Luma clinician the symptom timing, severity, last dose, and fluid intake so they can advise you.
Share this article